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Abstract
Background: Chromatin immunoprecipitation followed by sequencing of protein-bound DNA fragments (ChIP-
Seq) is an effective high-throughput methodology for the identification of context specific DNA fragments that are
bound by specific proteins in vivo. Despite significant progress in the bioinformatics analysis of this genome-scale
data, a number of challenges remain as technology-dependent biases, including variable target accessibility and
mappability, sequence-dependent variability, and non-specific binding affinity must be accounted for.
Results and discussion: We introduce a nonparametric method for scoring consensus regions of aligned
immunoprecipitated DNA fragments when appropriate control experiments are available. Our method uses local
models for null binding; these are necessary because binding prediction scores based on global models alone fail
to properly account for specialized features of genomic regions and chance pull downs of specific DNA fragments,
thus disproportionally rewarding some genomic regions and decreasing prediction accuracy. We make no
assumptions about the structure or amplitude of bound peaks, yet we show that our method outperforms leading
methods developed using either global or local null hypothesis models for random binding. We test prediction
performance by comparing analyses of ChIP-seq, ChIP-chip, motif-based binding-site prediction, and shRNA assays,
showing high reproducibility, binding-site enrichment in predicted target regions, and functional regulation of
predicted targets.
Conclusions: Given appropriate controls, a direct nonparametric method for identifying transcription-factor targets
from ChIP-Seq assays may lead to both higher sensitivity and higher specificity, and should be preferred or used in
conjunction with methods that use parametric models for null binding.
Background
Chromatin Immunoprecipitation (ChIP) is widely used to
discover in-vivo protein-bound or epigenetically modified
DNA regions, including binding sites for transcription
factors [1,2] and chromatin modification enzymes [3].
Knowledge about these sites and interactions lays the
foundation for investigating cellular processes in a variety
of contexts, including processes that guide development
and respond to stimuli. Protocols for ChIP vary, but in
general, after protein cross-linking and DNA fragmenta-
tion, specific antibodies are used to selectively immuno-
purify protein-bound DNA fragments, whose identity
and abundance are then determined by quantitative PCR
(ChIP) [4,5], microarray hybridization [6] (ChIP-chip) or
genome-wide sequencing [1] (ChIP-Seq).
ChIP-Seq allows identification of bound DNA sites
anywhere in the genome and has thus become the
method of choice for genome-wide profiling of protein
binding sites. ChIP-Seq is routinely used to screen for
transcription factor (TF) targets and binding sites,
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identifying TF targets that may be dysregulated by
changes to TF expression and activity. Despite its popu-
larity, however, this method continues to pose unique
data-analysis challenges, due to the significantly larger
amount of generated data and technological bias. The
assays used by this approach generally produce millions
of DNA fragment reads that were potentially bound to
a protein of interest, as well as large amounts of
background fragment reads that can contribute to false-
positive target predictions. Consequently, analysis meth-
ods find a balance between false-positive and false-
negative error rates, where false-positive predictions
need to be weeded out by additional assays and false-
negatives may result in missed interactions that are
informative about regulation in the screened cells.
Typically, reads are first aligned to a reference genome,
producing consensus regions with multiple matching
fragment reads. These are used to produce genome occu-
pancy histograms, whose peaks are then analyzed to eval-
uate their statistical significance, as the likelihood that
they were produced by random chance events (null
hypothesis), based on relatively simple models for ran-
dom fragment overlap, such as Poisson processes. Finally,
the peak-calling process separates those DNA regions
that are likely to be bound by the specific protein, at a
given statistical significance threshold, from those that
are more likely to correspond to false positive events.
A problem of most such approaches for null hypothesis
evaluation is that they use global probabilistic models
that may fail to fully account for both technical and
biologically-motivated local fluctuations in binding
probability.
Peak-calling methods that compute false positive like-
lihood (null hypothesis) by modeling chance DNA frag-
ment immunoprecipitation using a Poisson process
include MACS [7], USeq [8], QuEST [9], and SISSRs
[10]. Alternative null hypothesis evaluation methods
have been proposed, including the use of a negative
binomial distribution [11], binomial distributions that
are conditional on data from control experiments [8,12],
and hidden Markov models [13]. All of these approaches
adopt models that are uniformly computed across the
genome, subsequently failing to identify many relevant
binding regions [14,15]. PeakFinder [16], for instance,
calculates peak significance using a genome-wide Pois-
son distribution, thus discounting local bias.
To address some of these issues, MACS [7] combines
genome-wide and local models, by comparing candidate
peaks to an a priori null-model background derived from
genome-wide and local flanking regions, as well as from
control experiments. In contrast to the approach taken by
MACS, we take advantage of control experiments, when
available, to generate a fully unbiased, non-parametric
model, where no peak magnitude distribution is assumed
a priori. We then analyze whether such a model may be
effective in identifying bona fide binding sites that are
missed by PeakFinder and MACS, while maintaining high
specificity.
The dIP algorithm (differential ImmunoPrecipitation)
evaluates candidate DNA fragment consensus peaks
using a nonparametric genome-wide approach, after con-
ditioning on non-specific binding in control experiments.
dIP proceeds by first building a null distribution for non-
specific immunoprecipitation based on control experi-
ments to evaluate the statistical significance of candidate
consensus peaks (magnitude in Figure 1A) based on the
total number of DNA fragments supporting their occu-
pancy across both specific and non-specific (control)
antibody assays (amplitude in Figure 1A). After partition-
ing the genome into overlapping same-length segments,
dIP first evaluates each segment relative to others with
similar representation in the IP and control experiments,
choosing a minimum magnitude for each amplitude
(Figure 1B); note that the minimum magnitude is mono-
tonically coupled with the desired FDR cutoff, i.e. choos-
ing a higher minimum magnitude improves specificity at
the expense of sensitivity, see Methods for details. dIP
then joins neighboring segments with evidence for bind-
ing by the immunoprecipitated protein to produce con-
tiguous target region predictions. We show that this
intuitive scoring approach identifies sites that are missed
by PeakFinder and MACS, without increasing false posi-
tive calls, thus comparing favorably with these algorithms
both in terms of predictive power and cross-platform
reproducibility. Our results suggest that unbiased com-
parison against non-specific controls can help to signifi-
cantly improve the accuracy of ChIP-Seq analysis.
Results and discussion
To evaluate dIP’s performance, we compared the binding
sites inferred by dIP, PeakFinder, and MACS using multi-
ple ChIP-Seq datasets. The performance assessment was
done using multiple metrics, including enrichment of
functional targets using silencing datasets, concordance of
predictions obtained from other technologies and repro-
ducibility/consistency in predictions using replicated data-
sets. For evaluation we used ChIP-seq data for NOTCH1
in TALL cells [2,17], and NANOG and SOX2 in the
germ-cell tumor cell line NT2/D1[18], ETS1 in Jukart cells
[19]and FOXA1 in MCF7 cells [20]. To facilitate cross-
platform comparison and functional validation, we
restricted our analysis of gene-target predictions to sites
within 2 Kb from canonical transcription start sites.
Predictions
We compared the number of predicted target genes for
NOTCH1, NANOG and SOX2 ChIP-Seq data according
to dIP, MACS and PeakFinder. For this comparison, we
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identified all the genes with predicted target regions
within 2 kb of the TSS. While dIP and MACS identified
substantial number of target genes (~2000) for both
NANOG and SOX2, PeakFinder identified very few tar-
get genes (less than 100). Also we found significant varia-
bility in number of identified targets by PeakFinder,
where the number of identified targets varied from under
20 to greater than 6000 for NOTCH1. Consequently, we
removed PeakFinder from further comparisons.
In general, dIP predicted more target genes than
MACS and its predictions were assessed to be both
more functionally relevant and reproducible across repli-
cates and experimental technologies (Figures 2, 3).
Namely, dIP predicted more NOTCH1, NANOG, SOX2
and FOXA1 targets, and its predicted targets were more
likely to be down regulated (NOTCH1, NANOG, and
SOX2) or no longer bound (FOXA1) after transcription
factor (TF) silencing. A comparison of predicted
NOTCH1, NANOG and SOX2 target predictions using
ChIP-chip and ChIP-seq suggests that dIP predictions
are more likely to be confirmed by ChIP-chip, and a
comparison between ETS1 ChIP-seq replicates suggests
that dIP prediction are more reproducible.
ChIP-Seq peaks are enriched in silencing experiments
To check if dIP- and MACS-predicted target genes are
indeed functionally regulated, we compared predictions
from ChIP-seq [18] with results from differential expres-
sion analysis following the RNAi-mediated silencing of
NOTCH1, NANOG and SOX2. For these transcription
factors, silencing experiments were performed using len-
tivirus-mediated shRNA in TALL and NT2/D1 cells fol-
lowed by gene expression profiling. In addition, we
compared dIP- and MACS-predicted FOXA1 targets
before and after siRNA-mediated silencing of FOXA1 in
MCF7 cells [20].
Using a threshold of p-value ≤ 0.05 (Bonferroni cor-
rected) we identified genes that are differentially
expressed upon silencing NOTCH1, NANOG and SOX2.
The overlap between these differentially expressed genes
and target genes identified by dIP was 34%, 26% and 16%
of dIP-predicted targets whereas overlap with MACS-
identified target genes was 30%, 17% and 13% of MACS-
predicted targets, respectively for NOTCH1, NANOG,
SOX2 (Figure 2A) suggesting higher sensitivity for dIP-
predicted target genes. This suggests that dIP-predicted
target genes are more likely to be functionally regulated
by the three TFs.
We used MACS and dIP to infer FOXA1 binding sites
that are lost following its siRNA-mediated silencing in
MCF7 cells. dIP predicted over 2,500 targets in two
replicate experiments and fewer than 30% (27% and
21%) of these were retained after FOXA1 silencing,
while MACS predicted fewer than 2,000 targets and
nearly 40% of them were retained after silencing (39%
and 33%); see Figure 2B. These results suggest that dIP
has greater sensitivity, as its predicted sites are consis-
tently more dependent on FOXA1 abundance.
Concordance between ChIP-Seq and ChIP-chip predictions
We studied the concordance between target genes pre-
dicated by ChIP-Seq and ChIP-chip by considering how
frequently ChIP-Seq-predicted promoters were also pre-
dicted by ChIP-chip experiments. For this comparison
we used NOTCH1, NANOG, SOX2 target promoters,
predicted using × scores [21] from ChIP-chip data with
IgG controls in both cases. We partitioned predictions
from each method into two: those containing target
genes uniquely predicted by each method and those
containing common predictions. Target genes identified
by dIP but not by MACS (dIP-only) were more abun-
dant and were in better concordance with ChIP-chip
Figure 1 dIP significance estimates for bound genomic regions depend on both experiments (IP) and control. Significance is evaluated
using the number of IP fragments (magnitude) after conditioning for the total number of fragments aligned to the region (amplitude) in both
IP and control. (A) Minimum magnitudes for NANOG and SOX2 IP as a function of the amplitude to obtain FDR ≤ 0.1. (B) Minimum magnitude
(mmin) for a fixed amplitude is the magnitude necessary for achieving statistical significance at a given FDR cutoff. It is calculated as that value of
m at which the % of cumulative regions just crosses the FDR value. Here we present IP read count for regions with amplitude 20 in NANOG
ChIP-Seq data.
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Figure 2 Concordance between promoter occupancy predictions, and evidence for functional regulation and ChIP-chip predictions.
(A) The count of predicted promoters bound by NOTCH1, NANOG and SOX2 from ChIP-Seq data is given as data labels, while the proportion of
associated genes with evidence for functional regulation from RNAi studies is given on the y-axis. (B) The number of predicted targets for FOXA1 is
given as data labels, y-axis reports on the proportion of target predictions lost after TF silencing. (C) Common target gene predictions from ChIP-
chip and ChIP-Seq, where data labels give the absolute count of targets predicted from ChIP-Seq data, and the y axis gives the frequency that
these predictions were verified by ChIP-chip. We plot data for promoters that are predicted by dIP and not MACS, MACS but not dIP, and both dIP
and MACS. dIP predicted more target genes and its predictions agree better with ChIP-chip predictions. (D) Common gene target predictions from
ChIP-chip and ChIP-Seq as a function of decreasing ChIP-Seq binding scores. (E) Jaccard’s similarity coefficient was used to compare predicted
ETS1-target promoters using 3 replicate IPs and 4 replicate IgG control assays, comparing the average similarity between predictions across IgG
controls using the same IP (replicate IgG) or across IP assays with the same IgG control (replicate IP); error bars are given as S.E.M.
Figure 3 Comparison of binding site enrichment in predicted target regions. Frequency of motif-predicted binding sites for NOTCH1,
NANOG and SOX2 in dIP and MACS predicted bound regions as a function of dIP and MACS scores; bound regions are identified genome wide
and are not restricted to promoter regions.
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predicted target genes than targets identified by MACS
but not by dIP (MACS-only), while common predictions
outperformed predictions by individual methods for
NANOG, but not for SOX2; see Figure 2C. Namely,
dIP-only included 2324, 1799 and 670 NOTCH1,
NANOG and SOX2 targets, and 30%, 10% and 9% of its
predictions were in concordance with ChIP-chip data;
MACS-only included 66, 1047 and 184 targets for the
three TFs, and only 27%, 6% and 6% of its predictions,
respectively, were inferred from ChIP-chip data.
In order to evaluate the relative accuracy of dIP and
MACS scoring methods, we ranked predicted target
genes for both transcription factors using the highest
scoring regions in their promoters. We then evaluated
concordance with ChIP-chip predicted target genes by
considering the overlap in top n predictions from ChIP-
Seq, where n is varied from 1 to all predictions. Our
results suggest that top n dIP predicted-targets are in
better agreement than top n MACS predicted targets for
NOTCH1, NANOG and SOX2, when comparing both
for the overlap with ChIP-chip; see Figure 2D.
Reproducibility across multiple replicates
To test the reproducibility of target genes identified by
dIP using replicate experiments, we used the ETS1
ChIP-seq experiments [19] containing 3 replicates of IPs
and 4 replicates of IgG control assays. Assessment of
reproducibility was done using Jaccard’s similarity coeffi-
cient, which measures the ratio between sizes of the
intersection and union of target promoters to compare
predictions using the same IP and multiple IgGs (repli-
cate IgG), or the same IgG control for multiple IP assays
(replicate IP). Comparing predicted ETS1 target promo-
ters genes on 3 replicate IPs and 4 replicate IgG control
assays, suggested that dIP predictions are more consis-
tent (Figure 2E) across multiple replicates compared to
MACS predictions; Jaccard’s index was consistently at
least 10% higher for dIP predicted targets.
ChIP-Seq peaks are enriched for canonical binding sites
To test if dIP-predicted target regions for NANOG and
SOX2 are more likely to contain canonical binding sites,
we identified DNA-binding position-specific scoring
matrices for NOTCH1, NANOG and SOX2 from TRAN-
FAC [22] and JASPAR [23], as well as de novo motifs pre-
dicted by DME [24] by using ChIP-Seq data for NANOG
and SOX2, whose sites were enriched in peak regions pre-
dicted by MACS. Control regions, for each of both tran-
scription factors, were chosen as those where IgG binding
was significantly high relative to the given IP according to
MACS; these are predicted to be binding-depleted regions.
The TRANSFAC motifs M01111, M01123 and M01125
were most enriched, according to a tenfold cross valida-
tion procedure, for MACS-predicted NOTCH1, NANOG
and SOX2 binding sites, respectively. To measure enrich-
ment, we optimized the balanced error rate by maximiz-
ing the sum of the sensitivity and specificity of site
prediction [25]. MACS-predicted regions were enriched
for motif sites even at the lowest ranks, and dIP-
predicted regions had the highest binding site frequency
at top ranking regions. Note that here, regions can be
identified anywhere in the genome and are not restricted
to promoters.
Our results suggest that dIP-predicted target regions
for all three TFs are more likely to contain canonical
binding sites (Figure 3). Similarly, top scoring regions
according to dIP are more likely to contain canonical
binding sites than low scoring regions. Similar analysis
using the most enriched ETS1 motif (TRANSFAC motif
M00743) in the top 1000 MACS-predicted targets for
ETS1 dataset suggested comparable ETS1 canonical
binding site enrichment for both dIP and MACS target
regions (Figure S1, Additional file 1).
PCR validation of ChIP-Seq predictions
We used ChIP, followed by PCR to test the occupancy of
promoter regions that were predicted to bind to
NANOG and SOX2 by dIP and MACS; see Figure 4. In
total, we tested five and four promoters that were pre-
dicted to bind NANOG and SOX2, respectively, by both
dIP and MACS; six and seven promoters predicted to
bind by dIP but not MACS, two and four promoters to
bind by MACS but not dIP. As negative controls, we
include results for the top scoring promoters by MACS,
two for each of NANOG and SOX2 binding, when con-
trols were not used. In all cases, top predictions in each
category were tested. We note that in each of the ChIP-
Seq experiments we studied, over one thousand promo-
ters were predicted by MACS to be targeted by each of
NANOG and SOX2 only when controls were not used.
We expect that the majority of these are false predictions.
The result of our assay shows that dIP-predicted tar-
get-regions in promoters have high validation rates in
NT2/D1 cells based on individual ChIP-PCR assays of
22 dIP-predicted binding sites of the NANOG and
SOX2 transcription factors, including 13 sites predicted
by dIP but not by MACS. In addition, dIP detected 9 of
11 and 3 out of 11 targets previously validated for
NANOG and SOX2 [18], respectively, while MACS pre-
dictions included only 6 of 11 and 2 of 11 of these vali-
dated targets, respectively. Taken together, dIP and
MACS predicted 12 of 22 (55%) and 8 of 22 (36%) of
the validated targets for NANOG and SOX2 reported by
Jagadish et. al. [18], respectively.
Conclusions
We describe a non-parametric method for assigning sig-
nificance to binding peaks identified from ChIP-Seq data.
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Its scoring approach is intuitive and fast: a single scan of
the data is sufficient to identify genomic regions with
potential for binding. Then, these potential binding
regions are used to score and annotate full region
boundaries.
Our tests suggest that dIP identifies regions, and, con-
sequently, target genes that are missed by MACS, the
leading peak caller for ChIP-Seq. dIP-predicted targets
are more likely to have evidence for functional regulation
as suggested by comparing ChIP-seq data with silencing
experiments for NOTCH1, NANOG and SOX2, and are
in better agreement with both ChIP-chip and ChIP-PCR
(NANOG and SOX2) predictions. Moreover, dIP-
inferred TF-bound promoters are more enriched for
canonical binding sites of the respective TFs. Further-
more, dIP-predicted ETS1 binding sites are in better con-
cordance with predictions derived from multiple
replicate assays. Interestingly, our results suggest that
combining dIP and MACS predictions may identify
regions with the strongest binding affinity (Figure 2C
and 4). In total, dIP predictions showed higher sensitivity,
higher specificity, and higher reproducibility, based
on replicate experiments, functional assays, and
low-throughput validation.
Figure 4 Verification of promoter binding by PCR. Top predictions by both dIP and MACS were tested in two biological replicates, including
common predictions, dIP-only predictions, and MACS-only predictions. As negative controls (grey) we tested predictions made uniquely by
MACS with no control experiment input; error bars are given as S.E.M.
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The results of our assays support predictions by both
dIP and MACS, but suggest that common dIP- and
MACS-predicted promoters are more frequently bound
by the two transcription factors tested, and that targets
predicted by dIP have stronger binding evidence than
targets predicted by MACS and not by dIP. We believe
that dIP’s main advantage is in the elimination of any
reliance on parametric summaries of binding data.
Instead, dIP adopts direct control, exclusively relying on
experimental data to build its null distributions. In con-
trast, methods that rely on genome-wide summaries to
make predictions are prawn to make both false-positive
and false-negative calls in regions with greater and
lower non-specific binding, respectively.
ChIP-seq is widely used as an initial screen to identify
genes and pathways that are disrupted by changes in
expression or activity of transcription factors. For this
reason, it is important to reduce both false-positive and
false-negative prediction rates. While high false-positive
rates will make any technology more difficult to use,
high-false negative rates can result in failure to identify
key interactions. For example, dIP, but not MACS, pre-
dicted MYC targeting by NOTCH1 in TALL cells; a reg-
ulatory interaction that is thought to play a key role in
T cell acute lymphoblastic leukemia [2,17]. In fact, of 6
validated interactions presented in [2], MACS only pre-
dicted 3, compared to dIP’s 5. Given the proliferation of
ChIP-seq as a screening tool in both industry and aca-
demia, we believe that any improvement to its accuracy
will help improve our understanding of cellular signaling
in all contexts, including development and disease.
Methods
dIP algorithm
dIP starts by normalizing the number of IP and control
reads. Normalization essentially equates the number of
IP and control reads by increasing the size of the smal-
ler set through resampling with replacement. Then it
uses a three-step process to identify regions that are
enriched for immunoprecipitated fragments and score
them. First, dIP evaluates the statistical significance of
IP reads in segments of fixed length, based on a com-
parison between the distributions of mapped reads in
experiments using the specific antibody and controls (e.
g., IgG). Then it merges significant neighboring seg-
ments into likely bound genomic regions. In the third
and last step, it assigns a score to all the consolidated
regions using an intuitive scoring algorithm.
Fixed-length segment evaluation
Given an approximate lower bound L for the length of
immunoprecipitated DNA fragments, dIP scans the
whole genome in overlapping window (henceforth called
segment) of length L with each successive segment
starting at an offset of +
L
4
so that the consecutive seg-
ments overlap by 75% (3L/4). In each segment, the
number of IP reads (defined as magnitude, m) and the
number of total reads (defined as amplitude, a) is calcu-
lated, such that a = m + m¯ , where (m¯ ) is the number of
control reads in that segment. We identify the number
of genomic segments, N(a, m), for every ordered pair (a,
m). Note that for any particular amplitude a = a0, the
magnitude m can take any value from the set {0, 1,...a0-
1, a0}, thus generating a distribution of count, N(a0).
Next, we calculate the minimum magnitude, mmin, for
each amplitude, that is necessary for achieving statistical
significance at a given FDR cutoff of . mmin is calcu-







Thus, mmin is the minimum magnitude of IP reads
required out of the total reads a (amplitude), for IP
reads to be statistically significant in any segment of
amplitude a. It is obvious that the minimum magnitude
is monotonically coupled with the desired FDR cutoff.
In addition, we require mmin to increase monotonically
with a, and this is achieved by setting mmin at amplitude








We choose a gap length δ, such that statistically signifi-
cant segments that are closer than δ on the genome can
be merged into larger consolidated region predictions.
The merged regions thus obtained are checked for over-
all statistical significance, requiring that the ratio of con-
trol reads to total reads in merged region is less than
the FDR . Statistically significant merged regions with
minimum length k (predefined) are selected as candidate
bound regions. Throughout this manuscript, we set k =
150 and δ = 1000; note that k was chosen to match half
the expected fragment length (200-300 bases), while δ is
set wide enough so that a single binding site is not likely
to be represented by fragments with this gap length;
here two fragments that contain a single binding site are
expected to span at most 400-600 bases.
Note that dIP may predict long target regions, with
length exceeding 2000 bp; these candidate regions are
thought to contain multiple binding sites, and dIP
makes no attempt to narrow down their precise loca-
tion. Instead, given that our focus is on identifying tar-
get regions and quantifying the likelihood that these
regions are truly bound by the IPed protein, dIP simply
rewards these regions by scoring them higher.
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Scoring






, where m, m¯, a = m + m¯ , are the IP
and background counts, and the amplitude, respectively.
To get an intuitive understanding of this scoring
method, consider the Kullback-Leibler divergence, DKL
(X||Y), which measures the information loss when Y is







= DKL(m||m¯) − DKL(m¯||m)
In any region, if the IP(m) is highly significant, it will
have much more information than control (m¯ ). This is
to say that the information loss in approximating the IP
as control will be very high, so that the first DKL(m||m¯)
will be high; whereas the second DKL(m¯||m) will be
almost equal to zero as the information content of (m¯ )
is very less, and consequently there will be effectively no
information loss when (m¯ ) is coded as m. This will give
a high score to the highly significant binding regions.
Figure 1A gives mmin for both ChIP-Seq experiments as
a function of the amplitude, for  = 0.1. Throughout
the work reported here, we set  = 0.1 and L = 100.
To account for variability in length between MACS-
and dIP-predicted IP and IgG peaks, we set each region
length to 800 bases centered at the middle of the peak
region; 97% of MACS regions are shorter than 800
bases and so our regions cover MACS-predicted peaks.
MACS-1.4.2 was run with default parameters.
Comparing enrichment for canonical binding
For each chosen motif, and both IP regions and control
regions, as predicted by MACS, we used motif class [25]
to set optimal score cutoffs. motif class identifies score
cutoffs by optimizing balanced-error rates between IP
and control region sites, equal to 1-average (sensitivity,
specificity). Regions predicted to bind the immunopreci-
pitated protein were ranked by MACS score and parti-
tioned into 100-region bins. We then recorded the
number of regions in each bin that contained at least
one predicted site for the motif. The procedure was
repeated for dIP-predicted regions, using scores opti-
mized for MACS-predicted targets. As controls, we give
the total proportion of control regions that contained
sites for the motif.
Cell culture and immunoprecipitation protocol and
analysis
NT2/D1 cell cultures (70-80% confluent) were fixed by
adding formaldehyde (37% stock) directly to tissue culture
media to a final concentration of 1%. The crosslinking was
done for 10’ at RT by shaking [18]. The cross-linking
reaction was stopped by adding glycine to a final concen-
tration of 0.125 M for 5’ at RT with shaking. The cells
were washed thrice with ice-cold 1X PBS with 1 mM
PMSF (Protease Inhibitor). Cells were scraped from the
flask and pelleted by centrifugation. Cross-linked cells
were split into 3 × 106 aliquots and were sonicated in TE
buffer and Protease inhibitor cocktail (Roche). The soni-
cated DNA was checked by reversing cross links to get a
smear with maximum concentration in 100-200 bp range.
The sonicated DNA was immunoprecipitated using
anti-NANOG (R&D AF 1997, Minneapolis, MN, USA),
anti-SOX2 (R&D AF 2018, Minneapolis, MN, USA) and
anti-POU5F1 antibodies (R&D AF1759, Minneapolis, MN,
USA) as well as species and isotype-matched control anti-
bodies Goat IgG; R&D, Minneapolis, MN, USA) as control
for the specificity, following protocol from Odom et. al.
[26]. The precipitated complexes were reverse crosslinked
and DNA was purified by phenol-chloroform extraction.
The DNA was re-suspended in water for further analysis
by PCR. Single end 50-base reads from NANOG and
SOX2 ChIP-seq assays and 26-base reads from ETS1
ChIP-seq assays were aligned to hg19 using BWA [27],
with duplicates removed before running peak prediction.
MACS version 1.4.0 was ran with default parameters.
ChIP-PCR
PCR primers were designed to sequence regions sur-
rounding the canonical binding sites of the TFs in a 1 Kb
promoter region. Oligonucleotide sequences are given for
each of the target selected for DIP as well as MACS
result comparison below. All the PCRs were performed
using 2X Fast SYBR green master mixes (ABI) with 10 ng
of precipitated DNA for each sample. The PCR condi-
tions were 95°C-20 sec, 95°C-3 sec and 60°C-32 sec for
up to 40 cycles. PCR products were resolved on 2% agar-
ose gels and visualized by ethidium-bromide staining.
NANOG
LOC728743, Forward Primer (F) TCTGCTCAC-
CACCTCCGGGA, Reverse Primer (R) TCCATGGGCA-
CAATTGCTCTGCA; KIAA1147 (F) TGAGAACCCCA
AAATTACCG, (R) CTGTCAATGTCTCCAGGG-
CAGCT; KLRG2 (F) CCTGACCCTTCCCTCTTCTT, (R)
CCCCAATTCCTTTGGATTCT; NDUFV1 (F) GTCAT-
GAGGATCGGGCTATG, (R) GCCTTTGATGCCA-
CAAGTAAA; SOX2 (F) CCCCCAGCAGACTTCACAT,
(R) ccctcccatttccCTCGTTT; CASQ1 (F) AGGAGG-
GAAGGGGCCCTCAGT, (R) TGGGTCAGTTGAGG
TGCGGGA; DDX47 (F) TGGTTGTACATGATGGGT
CTG, (R) GGCCAAAGGAATAGCTTCAA; FAM115A
(F) AGTGTCTGGCACATGGAAAA, (R) GATTTG-
CAGggaaatgagga; MANIC1 (F) ACATGCCAGTCTC
TGTGTGC, (R) GGAGGTGATGTTTCCACTGGCCC;
PLBD1 (F) AGTAagaatcctttccAGATTGCTG, (R) CAGT
TCCTCCAACAGGAAGC; RNF103 (F) GTCTATCA
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CGCTACATGTCTATAAGG, (R) TCCTGAAAGT
GGAATGTAATTTGA; ATP5G3 (F) AAGAAAACg
gcaatgggtta, (R) CCCTCTCTGGTGCGTAGC; PRUNE2
(F) TAACTCCTGCAGTGGAGCAA, (R) gataaagagc
ccAGCCTTCTG; CYP2A6 (F) CCAAGGGTGGAGG
AGAGAG, (R) CCTCGACATCGTGTTTCTCTG; AC
TN2 (F) CACTGGAGAAAGAGGGACAGA, (R) TTCA
TTGGAGACCCCTCTTC;
SOX2
BTG2 (F) GGAGGAAGAGAGGCCAAGTT, (R) CTG
CCCAGGACCTCattaga; PRPS1L1 (F) AGCCCTGAAT
TTGAGAAGCA (R) TTGCTTCAGCTAGCCGAGTT;
VAMP1 (F) CattagttatggaaacTGTTCCAAG (R), CCA
AGATCTCTctttgggatg; WNT5B (F) GGGCGTGGA
AGCTGTTAGT, (R) CCCCCTTTTGATTTTCCTTC;
BCAT1 (F) CCCTTTTGTTAGGCCAGCTT, (R)TG
ATACACATGTAAATGGGATTGGA; BCAT1 (F) CAA
AAACGCGTAATTAACCACA, (R) TTTCTGGCTT
CCTCATGCTT; CENPF (F) GTTTTCCTCCCCTAC
CTGCT, (R) TTTTGCATCCCTAGTAACTTTGC; MO
SC2 (F) ATGCTGGGCTGCAAATGTA, (R) AGGAA
CTTTGCCATGGTGAG; NANOG (F) AGTCTGGG
TTACTCTGCAGCTACt, (R) AACCAGCTCAGTCCA
GCAGA; PTPRF (F) AGTTTCCTTTTCCAGCTGCTC,
(R) CCAGGGCACACAAAGCTG; SH2D3C (F) GTattta-
caaacaaaagAAAGCTGAG, (R) GTTGCTGGGCTGT
AGCTTG; SH2D3C (F) CACTCTGTGTTCCCAA
CCCTA, (R) CTCCTGCAGGCACTGTGTT; USF1 (F)
TGCTGCAGAGGAGACAGCTA (R) GTTCCTGAC
CCCCTGTTGT; BMPR2 (F) TCCCACTCTCTATCCC-
GACA, (R) GAGAGAGGGCCTGGATTCAC; FGF2 (F)
TTGTAACCTGTCCTCCTGTAAGTG, (R) CCCTGTG
GGTCTTTTCTCAG; KLHL5 (F) GAACCTACTttttct-
gattcttatTA, (R) TCTCAGAGCTTAAAGGGAACTCA;
ZNF146 (F) CAGTCACACAATCTACTCTCCACTG,
(R) GTGACTGGGTGCCGTAAAGT; GALNT9 (F)
GTCTGTGTGCCCGTGTGT, (R) CACATGAACAA




Additional file 1: Figure S1. Comparison of binding site enrichment in
predicted target regions for ETS1. Frequency of motif-predicted binding
sites for ETS1 in dIP and MACS predicted bound regions as a function of dIP
and MACS scores; bound regions are identified genome wide.
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